ATE470452T1 - Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien - Google Patents

Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien

Info

Publication number
ATE470452T1
ATE470452T1 AT00981507T AT00981507T ATE470452T1 AT E470452 T1 ATE470452 T1 AT E470452T1 AT 00981507 T AT00981507 T AT 00981507T AT 00981507 T AT00981507 T AT 00981507T AT E470452 T1 ATE470452 T1 AT E470452T1
Authority
AT
Austria
Prior art keywords
prostate
inflammation
treatment
vaccine containing
benign
Prior art date
Application number
AT00981507T
Other languages
English (en)
Inventor
Gyula Varga
Erika Lazar
Jozsef Bartus
Karoly Ujhelyi
Original Assignee
Vakcina Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vakcina Kft filed Critical Vakcina Kft
Application granted granted Critical
Publication of ATE470452T1 publication Critical patent/ATE470452T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00981507T 1999-11-25 2000-11-23 Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien ATE470452T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9904408A HU227086B1 (en) 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
PCT/HU2000/000122 WO2001037862A2 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Publications (1)

Publication Number Publication Date
ATE470452T1 true ATE470452T1 (de) 2010-06-15

Family

ID=90014600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981507T ATE470452T1 (de) 1999-11-25 2000-11-23 Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien

Country Status (20)

Country Link
US (4) US20080175865A1 (de)
EP (1) EP1272216B1 (de)
AT (1) ATE470452T1 (de)
AU (1) AU779214B2 (de)
CA (1) CA2394843C (de)
CZ (1) CZ302662B6 (de)
DE (1) DE60044539D1 (de)
DK (1) DK1272216T3 (de)
EA (1) EA005198B1 (de)
ES (1) ES2348591T3 (de)
HU (1) HU227086B1 (de)
IL (2) IL149779A0 (de)
PL (1) PL201804B1 (de)
PT (1) PT1272216E (de)
RO (1) RO122760B1 (de)
RS (1) RS51201B (de)
SI (1) SI20960B (de)
SK (1) SK288132B6 (de)
UA (1) UA78673C2 (de)
WO (1) WO2001037862A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723965A1 (de) * 2005-05-18 2006-11-22 Stallergenes Sa Zusammensetzungen zur Einleitung antigenspezifischer immunologischer Toleranz durch orale Immunisierung
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
HUP0700552A2 (en) 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
CN110996970A (zh) 2017-06-02 2020-04-10 亚利桑那州立大学董事会 创建个性化癌症疫苗的方法
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
CN111511378A (zh) * 2017-12-19 2020-08-07 杜邦营养生物科学有限公司 用于认知和心理健康的益生菌
EP4038222A4 (de) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Verfahren und zusammensetzungen zur identifizierung von neoantigenen zur verwendung bei der behandlung und vorbeugung von krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE19522472C2 (de) * 1995-06-21 1998-07-02 Eugen Baumgaertner Herstellungsverfahren eines Fermentationsproduktes zur Behandlung von Prostataleiden
ID24734A (id) * 1997-08-21 2000-08-03 New Zealand Dairy Board Bakteri asam laktat yang meningkatkan kekebalan
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Also Published As

Publication number Publication date
HUP9904408A2 (hu) 2002-03-28
EA005198B1 (ru) 2004-12-30
WO2001037862A3 (en) 2001-11-22
IL149779A (en) 2009-05-04
US20110243990A1 (en) 2011-10-06
WO2001037862A2 (en) 2001-05-31
UA78673C2 (en) 2007-04-25
HU227086B1 (en) 2010-06-28
YU37402A (sh) 2005-06-10
HUP9904408D0 (en) 2000-01-28
PT1272216E (pt) 2010-09-14
CA2394843A1 (en) 2001-05-31
CZ302662B6 (cs) 2011-08-24
US20180161414A1 (en) 2018-06-14
EA200200602A1 (ru) 2002-10-31
PL201804B1 (pl) 2009-05-29
ES2348591T3 (es) 2010-12-09
AU1874101A (en) 2001-06-04
IL149779A0 (en) 2002-11-10
CA2394843C (en) 2011-01-18
US9056073B2 (en) 2015-06-16
DE60044539D1 (de) 2010-07-22
EP1272216A2 (de) 2003-01-08
PL355886A1 (en) 2004-05-31
EP1272216B1 (de) 2010-06-09
US20080175865A1 (en) 2008-07-24
SI20960B (sl) 2011-01-31
RS51201B (sr) 2010-12-31
RO122760B1 (ro) 2010-01-29
US20160051657A1 (en) 2016-02-25
SK288132B6 (sk) 2013-10-02
DK1272216T3 (da) 2010-09-27
CZ20021771A3 (cs) 2002-11-13
SI20960A (sl) 2003-02-28
AU779214B2 (en) 2005-01-13
SK7382002A3 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
DE69718150D1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
ATE328091T1 (de) Oligoepitop-peptid des prostata-spezifischen antigens
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE69815310D1 (de) Zubereitungen zur tumorbehandlung enthaltend hai-knorpelextrakte und antineoplastische mittel
ATE279940T1 (de) Behandlung und prävention von helicobacter- infektionen
BR9913564A (pt) Tratamento de angiopatias microvasculares
ATE277943T1 (de) Trypsininhibitoren
DE60044539D1 (de) Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
ATE304365T1 (de) Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
NO20030137L (no) Fremgangsmåte for behandling av ustabil angina pectoris
DK1162985T3 (da) Matrixproteinsammensætninger til induktion af apoptose
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE69927815D1 (de) Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
EP1143981A4 (de) Behandlung und vorbeugung von hiv- und anderen virus infektionen
UA30787A (uk) Спосіб лікування хронічного персистуючого гепатиту
ATE459372T1 (de) Vorbeugung und behandlung von p. gingivalis infektion
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
FR2812549B1 (fr) Associations dalfopristine/quinupristine avec le cefpirome
UA32281A (uk) Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок
UA32314A (uk) Спосіб лікування некротичного панкреатиту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1272216

Country of ref document: EP